Table 1.
Gene | MutSigCV (q value) | intOGen (q value) | Chi-Square (q value) | Patients number (%) |
---|---|---|---|---|
TP53 | 0* | 0* | 2.60666E-21* | 52 (42.5%) |
FAT1 | 0* | 0* | 0* | 42 (35%) |
EPHA2 | 0* | 0* | 8.83024E-40* | 18 (15%) |
CDKN2A | 0* | 0* | 5.60405E-38* | 21 (17.5%) |
NOTCH1 | 0* | 0* | 2.27504E-21* | 35 (29.17%) |
CASP8 | 0* | 0* | 7.01792E-12* | 28 (23.33%) |
HRAS | 0* | 1.79995E-14* | 0.779955677 | 14 (11.67%) |
CHUK | 0* | 1.01941E-09* | 2.892E-07* | 6 (5%) |
RASA1 | 0* | 0.000329917* | 2.892E-07* | 6 (5%) |
ELAVL1 | 0* | 0.000715* | 0.000015424* | 8 (6.67%) |
PIK3CA | 0* | 0.444915251 | 0.779955677 | 21 (17.5%) |
RPTN | 0* | ND | 0.779955677 | 4 (3.33%) |
ASXL1 | 4.73E-05* | 0* | 6.86368E-21* | 3 (2.5%) |
AHNAK | 0.1394139 | 0.432185662 | 0.779955677 | 4 (3.33%) |
CHRNB4 | 0.01711482* | ND | 0.019808113* | 4 (3.33%) |
PEG3 | 0.1213081 | ND | 0.779955677 | 8 (6.67%) |
NHSL1 | 0.1347749 | 0.002388476* | 9.98024E-05* | 4 (3.33%) |
F2RL1 | 0.1347749 | 0.05191284* | 9.98024E-05* | 2 (1.67%) |
VEZF1 | 0.1347749 | 0.432185662 | 0.019808113* | 4 (3.33%) |
PPM1K | 0.1347749 | 0.467927377 | 0.779955677 | 3 (2.5%) |
TRIM67 | 0.1394139 | ND | 0.019808113* | 4 (3.33%) |
PKP3 | 0.2192678 | ND | 0.095549499* | 2 (1.67%) |
PDHA2 | 0.3252142 | ND | 0.779955677 | 5 (4.17%) |
H2BFWT | 0.3399323 | ND | 0.265724352 | 2 (1.67%) |
TMEM165 | 0.3457312 | 0.05191284* | 0.779955677 | 2 (1.67%) |
PTPN14 | 0.3468882 | 0.002186196* | 4.32573E-07* | 3 (2.5%) |
PPM1D | 0.3468882 | 0.05191284* | 9.98024E-05* | 2 (1.67%) |
ATG4C | 0.3707801 | 0.077115199* | 0.007211938* | 3 (2.5%) |
*Statistically significant genes, q<0.1.